Effect of rifaximin in severe cirrhotic patients with ascites: a double-blind randomized placebo-controlled phase 3 trial

被引：0

作者：

Thevenot, Thierry ^{[1
]}

Elkrief, Laure ^{[2
]}

Bureau, Christophe ^{[3
]}

Bardou-Jacquet, Edouard ^{[4
]}

Rosa, Isabelle ^{[5
]}

Khac, Eric Nguyen ^{[6
]}

Oberti, Frederic ^{[7
]}

Pitta, Anais ^{[8
]}

Mallet, Maxime ^{[9
]}

Lebosse, Fanny ^{[10
]}

Louvet, Alexandre ^{[11
]}

Meunier, Lucy ^{[12
]}

Nahon, Pierre ^{[13
]}

Ollivier-Hourmand, Isabelle ^{[14
]}

Anty, Rodolphe ^{[15
]}

Francoz, Claire ^{[16
]}

Riachi, Ghassan ^{[17
]}

Meunier, Alexandre ^{[18
]}

Tio, Gregory ^{[19
]}

Muller, Allison ^{[20
]}

Cure-Martin, Audace ^{[21
]}

Hocquet, Didier ^{[18
]}

Di Martino, Vincent ^{[1
]}

Weil-Verhoeven, Delphine ^{[1
]}

Desmarets, Maxime

机构：

[1] CHU Besancon, Dept Hepatol, Besancon, France

[2] CHU Tours, Dept Hepatogastroenterol, Tours, France

[3] CHU Toulouse, Dept Hepatol, Toulouse, France

[4] CHU Rennes, Dept Liver Dis, Rennes, France

[5] CHI Creteil, Dept Hepatogastroenterol, Creteil, France

[6] CHU Amiens, Dept Hepatogastroenterol, Amiens, France

[7] CHU Angers, Dept Hepatogastroenterol, Angers, France

[8] CHU Reims, Dept Hepatogastroenterol, Reims, France

[9] CHU Pitie Salpetriere, Dept Hepatogastroenterol, Paris, France

[10] Hosp Civils Lyon, Dept Hepatol, Hop Croix Rousse, Lyon, France

[11] Hop Huriez, Serv Malad Appareil Digestif, Lille, France

[12] CHU Montpellier, Dept Heptogastroenterol & Liver Transplantat, Montpellier, France

[13] Hop Univ Paris Seine St Denis, Liver Unit, Bobigny, France

[14] CHU Caen, Dept Hepatogastroenterol, Caen, France

[15] CHU Nice, Dept Hepatol, Nice, France

[16] Hop Beaujon, Liver Intens Care & Liver Transplantat Unit, Clichy, France

[17] Hop Charles Nicolle, Dept Hepatogastroenterol, Rouen, France

[18] CHU Besancon, Ctr Ressources Biol Filiere Microbiol, Besancon, France

[19] CHU Besancon, Ctr Invest Clin 1431, UMETh, Besancon, France

[20] CHU Besancon, Dept Clin Res & Innovat, Vigilance Unit, Besancon, France

[21] Ctr Invest Clin, Inserm CIC 1431, Besancon, France

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OS-097

引用

页码：S61 / S62

页数：2

共 50 条

[41] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL ON THE EFFECT OF MAGNESIUM OXIDE IN PATIENTS WITH CHRONIC CONSTIPATION
Mori, Sumire
Tomita, Toshihiko
Nakamura, Kumiko
Tamura, Akio
Ogawa, Tomohiro
Yamasaki, Takahisa
Okugawa, Takuya
Kondo, Takashi
Kono, Tomoaki
Tozawa, Katsuyuki
Oshima, Tadayuki
Fukui, Hirokazu
Kimura, Takeshi
Watari, Jiro
Miwa, Hiroto
GASTROENTEROLOGY, 2019, 156 (06) : S599 - S599
[42] Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study
Isaacs, Kim L.
Sandler, Robert S.
Abreu, Maria
Picco, Michael F.
Hanauer, Stephen B.
Bickston, Stephen J.
Present, Daniel
Farraye, Francis A.
Wolf, Douglas
Sandborn, William J.
INFLAMMATORY BOWEL DISEASES, 2007, 13 (10) : 1250 - 1255
[43] PRIMARY PROPHYLAXIS OF BACTERIAL-INFECTIONS WITH NORFLOXACIN IN CIRRHOTIC-PATIENTS WITH ASCITES - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
GRANGE, JD
ROULOT, D
PELLETIER, G
PARIENTE, A
DENIS, J
INK, O
BLANC, P
RICHARDET, JP
VINEL, JP
AMIOT, X
DELISLE, F
FISCHER, D
BODIN, F
GASTROENTEROLOGY, 1994, 106 (04) : A901 - A901
[44] A multicenter, double-blind, randomized, placebo-controlled study of rifaximin for the treatment of bacterial vaginosis
Donders, Gilbert G. G.
Guaschino, Secondo
Peters, Klaus
Tacchi, Raffaella
Lauro, Vittoria
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2013, 120 (02) : 131 - 136
[45] A Randomized, Double-Blind, Placebo-Controlled Clinical Effect of a Xanthone-rich Dietary Supplement on Immune Function in Humans: A Randomized Double-Blind Placebo-Controlled Trial
Tang, Yu-Ping
Li, Peng-Gao
Ji, Hongping
Kou, Yan
FASEB JOURNAL, 2008, 22
[46] Antithrombin III in patients with severe sepsisA randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
B. Eisele
H. Heinrichs
U. Delvos
M. Lamy
L. G. Thijs
H. O. Keinecke
H. P. Schuster
F. R. Matthias
F. Fourrier
Intensive Care Medicine, 1998, 24 : 663 - 672
[47] Antithrombin III in patients with severe sepsis - A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
Eisele, B
Lamy, M
Thijs, LG
Keinecke, HO
Schuster, HP
Matthias, FR
Fourrier, F
Heinrichs, H
Delvos, U
INTENSIVE CARE MEDICINE, 1998, 24 (07) : 663 - 672
[48] A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia
Kuriakose, Moni Abraham
Ramdas, Kunnambath
Dey, Bindu
Iyer, Subramanya
Rajan, Gunaseelan
Elango, Kalavathy K.
Suresh, Amritha
Ravindran, Divya
Kumar, Rajneesh R.
Prathiba, R.
Ramachandran, Surya
Kumar, Nisha Asok
Thomas, Gigi
Somanathan, Thara
Ravindran, Hiran K.
Ranganathan, Kannan
Katakam, Sudhakar Babu
Parashuram, Shivashankar
Jayaprakash, Vijayvel
Pillai, M. Radhakrishna
CANCER PREVENTION RESEARCH, 2016, 9 (08) : 683 - 691
[49] Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Butchart, Joseph
Brook, Laura
Hopkins, Vivienne
Teeling, Jessica
Puentener, Ursula
Culliford, David
Sharples, Richard
Sharif, Saif
McFarlane, Brady
Raybould, Rachel
Thomas, Rhodri
Passmore, Peter
Perry, V. Hugh
Holmes, Clive
NEUROLOGY, 2015, 84 (21) : 2161 - 2168
[50] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL
Tufan, Ayse N.
Tufan, Fatih
NEUROLOGY, 2015, 85 (23) : 2083 - 2084

← 1 2 3 4 5 →